NOVEOS Specific IgE (sIgE) +5 more— 510(k) K260280

Substantially Equivalent

Hycor Biomedical

FDA 510(k) clearance K260280 for NOVEOS Specific IgE (sIgE) +5 more, Substantially Equivalent on 2026-06-18. Applicant: Hycor Biomedical. Device class: 2.

Summary

Hycor Biomedical's clearance covers NOVEOS Specific IgE (sIgE) and five capture reagents: F004 (wheat), F023 (crab), F079 (gluten, wheat), F202 (cashew nut), and F233 (Gal d 1 ovomucoid egg). They're filed under DHB, radioallergosorbent (RAST) immunological test systems.

Class II, 21 CFR 866.5750. Immunology is both the classification panel and the review panel, and the submission was a Traditional 510(k).

Hycor filed from Garden Grove, California. The decision came 140 calendar days after receipt (January 29 to June 18, 2026).

Clearance details

Device name as filed
NOVEOS Specific IgE (sIgE); Capture Reagent F004, Wheat (Triticum aestivum); Capture Reagent F023, Crab (Callinectes spp.); Capture Reagent F079, Gluten, Wheat; Capture Reagent F202, Cashew Nut (Anacardium occidentale); Capture Reagent F233, Gal d 1 Ovomucoid Egg
Applicant
Hycor Biomedical
Product code
Product code DHB
Device class
Class 2
Regulation
21 CFR 866.5750
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Garden Grove, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DHB

view all

More clearances from Hycor Biomedical

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.